Articles in 2022

Filter By:

  • Structure and mutagenesis of the colibactin-activating peptidase ClbP reveals a dimer with a substrate-binding transmembrane domain and a conserved polar network in its periplasmic domain that enforces selectivity for d-asparagine prodrug motifs.

    • José A. Velilla
    • Matthew R. Volpe
    • Rachelle Gaudet
    ArticleOpen Access
  • A substrate-guided design strategy generated highly potent inhibitors of the biosynthesis of the genotoxin colibactin by human gut bacteria. These inhibitors also enable a generalizable approach for chemically guided natural product discovery.

    • Matthew R. Volpe
    • José A. Velilla
    • Emily P. Balskus
    ArticleOpen Access
  • Prostate tumors, resistant to current antiandrogen therapies, represent a serious clinical challenge. A new report identifies androgen-receptor-dependent liquid condensates as being responsible in part for therapeutic resistance, but, encouragingly, also reveals a novel vulnerability amenable to drug targeting.

    • Iain J. McEwan
    News & Views
  • The fungal sterol receptor and transcription factor Upc2 activates the transcription of ergosterol biosynthesis genes in response to ergosterol depletion in yeast. A structural and biochemical study reveals an Hsp90-dependent translocation activation mechanism of Upc2, with implications for triazole antifungal resistance.

    • P. David Rogers
    News & Views
  • Unbiased metabolomics revealed the conversion of serotonin into N-acetylserotonin-derived glucosides by an intestinal carboxylesterase in Caenorhabditis elegans, which suggests an unappreciated role of the gut in modulating 5-HT signaling.

    • Ji Y. Sze
    News & Views
  • The gut microbiota has a key role in protecting hosts from pathogens. A new study identified a gut microbiota-derived bile acid (chenodeoxycholic acid) that inhibits bacterial infection by interacting with a regulatory protein necessary for the expression of virulence factors.

    • Deyanira Pérez-Morales
    • Víctor H. Bustamante
    News & Views
  • An INSPIRE platform for therapeutic regulators and sensors, based on split human domains binding physiological or clinically approved compounds, has been developed and demonstrated on several human proteins in a relevant ligand concentration range.

    • Erik Rihtar
    • Tina Lebar
    • Roman Jerala
    Article